Cantor Fitzgerald analysts maintained their Overweight rating and $19.00 price target for Avita Medical Ltd . (NASDAQ:RCEL) stock, despite the shares being down nearly 50% over the past year.

A former S&P executive shares his views of U.S. creditworthiness under President Trump.

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

The report, entitled Unlocking Operational Excellence in Fund Administration through AI, is based on insights from in-depth ...

Shares of FactSet Research Systems Inc. FDS rose 1.14% to $459.39 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6, ...

The American Council on Education & the Carnegie Foundation have released an updated classification of colleges, resulting in ...

Shares of CVS Health Corp. were having their best day in 26 years on Wednesday, after the drugstore chain and healthcare-services company beat quarterly profit expectations by a wide margin, and as ...

WEC Energy boosts its dividend for the 22nd year, with strong growth prospects and a $28B investment plan. Find out why WEC ...

The S&P 500 ended Tuesday near the flat line as investors digested cautious commentary from Federal Reserve Chair Jerome ...

Wells Fargo lowered the firm’s price target on FactSet (FDS) to $500 from $503 and keeps an Equal Weight rating on the shares. The acquisition ...